Spineway SA (FRA:37S)

Market Cap	3.31M +25.9%
Revenue (ttm)	11.80M -1.6%
Net Income	-1.90M
EPS	-0.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,173
Average Volume	47,724
Open	0.1520
Previous Close	0.1512
Day's Range	0.1520 - 0.1538
52-Week Range	0.0794 - 0.2625
Beta	n/a
RSI	47.77
Earnings Date	Feb 17, 2026

About Spineway

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2005
• Employees: 43
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 37S

Financial Performance

In 2024, Spineway's revenue was 12.73 million, an increase of 12.11% compared to the previous year's 11.36 million. Losses were -3.87 million, -40.63% less than in 2023.